Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/15/24 06:30:00 on US and Canada Markets.
DENVER, April 15, 2024 (GLOBE NEWSWIRE) -- ArrowMark Financial Corp., (NASDAQ: BANX) ("ArrowMark Financial"), today announced that BANX’s estimated and unaudited Net Asset Value (“NAV”) as of March 28, 2024, was $21.24. This estimated NAV is not a comprehensive statement ...
CALGARY, Alberta, April 15, 2024 (GLOBE NEWSWIRE) -- TSX-V: CWV: Crown Point Energy Inc. (“Crown Point”, the “Company”, " we " or " our " ) is pleased to provide an update on the status of its proposed acquisition of a 100% working interest in...
FDA Fast Track designation granted for TLX101-CDx for glioma (brain cancer) imaging Collaboration agreement announced for joint development and commercialisation with UCSF PharmaLogic announced as commercial manufacturing and pharmacy distribution partner MELBOURNE, Au...
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- PIMCO Corporate & Income Strategy Fund (NYSE: PCN), PIMCO High Income Fund (NYSE: PHK), PIMCO Income Strategy Fund (NYSE: PFL), PIMCO Income Strategy Fund II (NYSE: PFN) and PIMCO Corporate & Income Opportunity Fund (NYSE: PTY) (each, a “...
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- PIMCO Corporate & Income Strategy Fund (NYSE: PCN), PIMCO High Income Fund (NYSE: PHK), PIMCO Income Strategy Fund (NYSE: PFL), PIMCO Income Strategy Fund II (NYSE: PFN) and PIMCO Corporate & Income Opportunity Fund (NYSE: PTY) (each, a “...
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- PIMCO Corporate & Income Strategy Fund (NYSE: PCN), PIMCO High Income Fund (NYSE: PHK), PIMCO Income Strategy Fund (NYSE: PFL), PIMCO Income Strategy Fund II (NYSE: PFN) and PIMCO Corporate & Income Opportunity Fund (NYSE: PTY) (each, a “...
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- PIMCO Corporate & Income Strategy Fund (NYSE: PCN), PIMCO High Income Fund (NYSE: PHK), PIMCO Income Strategy Fund (NYSE: PFL), PIMCO Income Strategy Fund II (NYSE: PFN) and PIMCO Corporate & Income Opportunity Fund (NYSE: PTY) (each, a “...
2024-04-15 18:15:02 ET Evercore ISI analyst issues OUTPERFORM recommendation for TER on April 15, 2024 04:35PM ET. TER was trading at $104.42 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 5 - Buy, 2 - H...
2024-04-15 18:15:02 ET Evercore ISI analyst issues OUTPERFORM recommendation for MCHP on April 15, 2024 04:36PM ET. MCHP was trading at $85.7 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Strong Buy...
2024-04-15 18:15:02 ET Evercore ISI analyst issues OUTPERFORM recommendation for KLAC on April 15, 2024 04:34PM ET. KLAC was trading at $678.49 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 7 - Buy, 4 -...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
13.54%Change Percent:
NLS Pharmaceutics Ltd. Company Name:
NLSP Stock Symbol:
NASDAQ Market: